Ryesino Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.83 M
as on 16-12-2024
- Company Age 41 Year, 6 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.45 M
as on 16-12-2024
- Satisfied Charges ₹ 9.50 M
as on 16-12-2024
- Revenue 6.50%
(FY 2022)
- Profit -1.77%
(FY 2022)
- Ebitda -71.34%
(FY 2022)
- Net Worth 22.32%
(FY 2022)
- Total Assets 44.37%
(FY 2022)
About Ryesino Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.83 M.
The company currently has active open charges totaling ₹6.45 M. The company has closed loans amounting to ₹9.50 M, as per Ministry of Corporate Affairs (MCA) records.
Jaidesh Wason, Renu Wason, Sachin Wason, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110UP1983PTC006356
- Company No.
006356
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 1983
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ryesino Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaidesh Wason  | Managing Director | 15-Dec-1983 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Renu Wason | Director | 18-Dec-1986 | Current |
| Sachin Wason | Director | 27-Mar-2000 | Current |
| Shagun Wason | Director | 01-Jun-2003 | Current |
Financial Performance of Ryesino Pharmaceuticals.
Ryesino Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.5% increase. The company also saw a slight decrease in profitability, with a 1.77% decrease in profit. The company's net worth Soared by an impressive increase of 22.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ryesino Pharmaceuticals?
Unlock access to Ryesino Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Doon Health Services Private LimitedActive 3 years 1 monthJaidesh Wason and Sachin Wason are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 18 Nov 2005 | ₹6.00 M | Open |
State Bank Of India Creation Date: 08 Sep 2000 | ₹0.45 M | Open |
State Bank Of India Creation Date: 22 May 2007 | ₹9.50 M | Satisfied |
How Many Employees Work at Ryesino Pharmaceuticals?
Unlock and access historical data on people associated with Ryesino Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ryesino Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ryesino Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
